KUALA LUMPUR (Aug 24): Most glove counters, except for Supermax Corp Bhd, failed to sustain their upward momentum in the morning trade today, landing on the top losers list of Bursa Malaysia amid a lack of fresh catalysts to trigger further buying interest.

The news that a Covid-19 treatment involving the use of blood plasma from recovered patients will be expanded to more Americans might have dampened the sentiment while the race to develop a vaccine continues.

At noon break, Hartalega Bhd topped the losers list, down 48 sen or 2.7% to RM17.26, followed by Kossan Rubber Industries Bhd, which lost 44 sen or 2.68% to RM15.96. Top Glove Corp Bhd slipped six sen or 0.2% to RM27.94 with 10.7 million shares traded.

Supermax bucks the trend, it was up 20 sen or 0.9% to RM22.10, hovering in a tight range between RM22 and RM22.50 throughout the morning trading session.

Among the smaller players, Rubberex Corp (M) Bhd was the biggest loser, shedding 24 sen or 4.14% to RM5.56. Careplus Group Bhd fell 12 sen or 2.87% to RM4.06, while Comfort Gloves Bhd slid three sen or 0.63% to RM4.76.

Meanwhile, Supermax’s warrants were actively traded this morning, some of which found their way to the top gainers list. Supermax-C78 was third on the list, up by 43 sen or 4.33% to RM10.36 apiece, while Supermax-C87 was in ninth place, rising 30 sen or 3.75% to RM8.29.

US President Donald Trump said the US Food and Drug Administration (FDA) will be offering the use of what is known as convalescent plasma to certain patients, paving the way for easier access to the treatment.

While Trump has hailed the treatment as a “powerful therapy”, studies to prove its benefits have not been concluded yet.

Edited by Kathy Fong